FDA recalls magnesium sulfate after IV bag mix-up
A nationwide hospital-level recall is underway for one lot of magnesium sulfate after FDA said a pouch was found to contain tranexamic acid instead. The issue matters because both drugs are used in urgent care, but FDA said it had not received adverse-event reports at the time of the announcement.
The FDA says Amneal Pharmaceuticals is recalling one lot of magnesium sulfate in water for injection after a pouch was found to contain tranexamic acid instead. The recall was issued at the hospital level and affects a product used in urgent care settings.
For patients and families, the main takeaway is simple: this is a medication mix-up, not a shortage. If you or a loved one recently received IV medications in the hospital, it is reasonable to ask what was given and to review discharge paperwork.
Why this recall matters
Even when the chance of exposure is considered low, IV medication mix-ups are serious because hospitals use these drugs in time-sensitive situations. Magnesium sulfate and tranexamic acid serve very different purposes, so a labeling or packaging error can create a real safety risk if the wrong product reaches a patient.
What the two drugs are used for
According to the FDA, magnesium sulfate in water for injection is used to prevent and control seizures in preeclampsia and eclampsia, pregnancy complications that can become emergencies. Tranexamic acid is used for certain bleeding-related situations, including short-term use in patients with hemophilia to reduce or prevent hemorrhage during and after tooth extraction.
Who may want to pay attention
This recall is most relevant to recently hospitalized patients, pregnant patients, and families checking recent IV medications. Hospitals, distributors, pharmacists, and other health care facilities are also part of the recall process because the product was distributed nationwide.
What FDA said about possible risks
The FDA said that if tranexamic acid is given by mistake, it could lead to blood clotting, seizures, hypersensitivity reactions, visual disturbances, and dizziness. The agency also said Amneal had not received adverse-event reports related to the recall at the time of the announcement.
FDA added that a delay in receiving magnesium therapy could be dangerous for pregnant people with preeclampsia or eclampsia because of seizure risk, and could also affect preterm newborn outcomes if needed magnesium is delayed.
What readers and families can do
If you are concerned about a recent hospital stay, ask the hospital or pharmacy what IV medication was administered and compare that with the discharge summary or medication list. If someone has concerning symptoms after a recent infusion, seek urgent medical care right away, especially for seizures, trouble breathing, signs of a severe allergic reaction, new neurological symptoms, or symptoms your clinician told you to watch for.
For hospitals and distributors, FDA said the affected product should be stopped and returned to the manufacturer. The agency also said this action was a recall, not a shortage, which means the concern is product mix-up and safety rather than nationwide supply.
For general readers, the practical point is to keep recent hospital medication records handy and ask questions if an IV treatment does not match what you expected.
Sources
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
